Smruthi Organics Ltd

Smruthi Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 May 2026, providing investors with the latest insights into its performance and outlook.

Smruthi Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, signalling a notable shift from its previously positive growth trajectory. Despite a higher profit after tax (PAT) for the nine-month period, the company’s net sales have contracted sharply, prompting a downgrade in its Mojo Grade from Hold to Sell.

Smruthi Organics Ltd., a micro-cap pharmaceutical company with a market capitalisation of ₹130.00 crores, reported a sequential recovery in profitability for the quarter ending March 2026, though the underlying revenue trends remain concerning. Net profit for Q4 FY26 stood at ₹1.07 crores, marking a decline of 23.60% quarter-on-quarter from ₹1.40 crores in Q3 FY26, whilst representing a sharp 52.02% decline year-on-year from ₹2.23 crores in Q4 FY25.

Smruthi Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 12 May 2026. This shift reflects a combination of deteriorating technical indicators, subdued long-term financial growth, and valuation concerns despite some recent positive earnings momentum. The company’s Mojo Score now stands at 48.0, signalling caution for investors amid a challenging market backdrop.

Smruthi Organics Ltd has seen its investment rating upgraded from Sell to Hold as of 4 May 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial performance, and quality assessments. This upgrade comes amid a micro-cap pharmaceutical sector backdrop where the company’s recent quarterly results and technical signals have shifted investor sentiment, warranting a closer examination of the factors driving this change.

Smruthi Organics Ltd has seen its investment rating downgraded from Hold to Sell as of 28 Apr 2026, reflecting a shift in technical indicators and concerns over its long-term growth prospects despite recent positive financial results. The company’s current Mojo Score stands at 48.0, with a micro-cap market capitalisation and a day-on-day price decline of 3.09%. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have influenced this rating change.

Smruthi Organics Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable shift in technical indicators and improving financial metrics. The micro-cap pharmaceutical company’s recent performance and valuation adjustments have prompted analysts to revise their outlook, signalling cautious optimism amid mixed long-term growth trends.

Smruthi Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Smruthi Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 March 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 11 April 2026, providing investors with the most up-to-date analysis.

For the third consecutive session, Smruthi Organics Ltd has declined, culminating in a fresh 52-week low of Rs 95 on 1 Apr 2026. This marks an 11.81% drop over the last three days, underscoring persistent selling pressure despite some positive financial indicators.

Smruthi Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 March 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 31 March 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

For the second consecutive session, Smruthi Organics Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 102 on 30 Mar 2026. This latest drop extends the stock’s recent underperformance despite some positive financial indicators.

Smruthi Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 20 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Smruthi Organics Ltd has seen its investment rating downgraded from Hold to Sell as of 6 March 2026, reflecting a shift in technical indicators and concerns over its long-term financial growth. Despite some positive quarterly results and attractive valuation metrics, the company’s overall performance and technical trends have prompted a cautious stance among investors.

Smruthi Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 4 March 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors.

Smruthi Organics Ltd is rated Sell by MarketsMOJO. This rating was last updated on 06 February 2026, reflecting a change from the previous Hold rating. However, all fundamentals, returns, and financial metrics discussed here are current as of 03 March 2026, providing investors with the latest assessment of the stock’s position.